ロード中...
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors
BACKGROUND: The oncogenic activity of the high risk human papillomavirus type 16 (HPV16) is fully dependent on the E6 and E7 viral oncoproteins produced during viral infection. The oncoproteins interfere with cellular homeostasis by promoting proliferation, inhibiting apoptosis and blocking epitheli...
保存先:
| 出版年: | J Exp Clin Cancer Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7825221/ https://ncbi.nlm.nih.gov/pubmed/33485370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-021-01841-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|